Crossmark

Effects of ketamine administration on the phosphorylation levels of CREB and TrKB and on oxidative damage after infusion of MEK inhibitor

Crossref DOI link: https://doi.org/10.1016/j.pharep.2015.08.010

Published Print: 2016-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Réus, Gislaine Z.

Abaleira, Helena M.

Titus, Stephanie E.

Arent, Camila O.

Michels, Monique

da Luz, Jaine R.

dos Santos, Maria Augusta B.

Carlessi, Anelise S.

Matias, Beatriz I.

Bruchchen, Livia

Steckert, Amanda V.

Ceretta, Luciane B.

Dal-Pizzol, Felipe

Quevedo, João
Funding

Funding for this research was provided by:

CNPq (JQ, FDP and GZR)

FAPESC (JQ and FDP)

Instituto Cérebro e Mente

UNESC (JQ)

ĹOréal/UNESCO/ABC Brazil Fellowship

Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston
License Information

Text and Data Mining valid from 2016-02-01
More Information

This article is maintained by: Elsevier

Article Title: Effects of ketamine administration on the phosphorylation levels of CREB and TrKB and on oxidative damage after infusion of MEK inhibitor

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2015.08.010

Content Type: article

Copyright: Copyright © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.